Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-033405
Filing Date
2017-05-17
Accepted
2017-05-17 18:45:18
Documents
1
Period of Report
2017-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15598
  Complete submission text file 0001209191-17-033405.txt   17246
Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY NJ 07054
Business Address
Williams Kristen Marie (Reporting) CIK: 0001296965 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 17853104

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations